Post-COVID-19 olfactory dysfunction: carbamazepine as a treatment option in a series of cases

Olfactory dysfunction is reported frequently in patients with coronavirus disease 2019. However, an effective treatment for this dysfunction is unknown. The present study evaluated carbamazepine as a treatment option for olfactory dysfunction based on its use in cases of neuralgia, especially of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Vasconcelos, Claudia Cristina Ferreira, Hammerle, Mariana Beiral, Sales, Deborah Santos, Rueda Lopes, Fernanda Cristina, Pinheiro, Patricia Gomes, Gouvea, Elisa Gutman, Alves, Manuella Caroline Dutra Frazão, Pereira, Tayane Vasconcellos, Schmidt, Sergio Luis, Alvarenga, Regina Maria Papais, Pires, Karina Lebeis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976535/
https://www.ncbi.nlm.nih.gov/pubmed/35366736
http://dx.doi.org/10.1007/s13365-022-01066-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976535/
https://www.ncbi.nlm.nih.gov/pubmed/35366736
http://dx.doi.org/10.1007/s13365-022-01066-3

Ejemplares similares